4//SEC Filing
TAHL CINDY 4
Accession 0001209191-23-002977
CIK 0001434316other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:08 PM ET
Size
5.7 KB
Accession
0001209191-23-002977
Insider Transaction Report
Form 4
TAHL CINDY
See Remarks
Transactions
- Sale
Common Stock
2023-01-10$5.24/sh−11,553$60,538→ 177,598 total
Footnotes (2)
- [F1]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the Reporting Person on January 8, 2020, 4,503 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021, and 8,325 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell to cover" transactions and do not represent discretionary trades by the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold ranging from $5.12 to $5.36 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001655472
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 4:08 PM ET
- Size
- 5.7 KB